Wednesday - March 25, 2026

Hip Reconstruction/Replacement Devices Market Set for Steady Growth at 5.51% CAGR Through 2034: DelveInsight | Zimmer Biomet, Stryker Corporation,Smith & Nephew and Others

Hip Reconstruction/Replacement Devices Market Insights The global hip replacement devices market is poised for robust and sustained expansion, driven by the rising prevalence of bone-related disorders and continuous technological advancements by global players including, Exactech, Inc., Johnson & Johnson Services, … Continue reading

DigiMarCon Canada West 2026 Returns to Vancouver, Bringing the Future of Digital Marketing to the Global Stage

Vancouver, BC – DigiMarCon Canada West, the premier digital marketing, media, advertising, and business conference and exhibition in the BC, will return April 20-21, 2026, at the Paradox Hotel Vancouver in Vancouver, BC. The three-day event will unite marketers, brands, … Continue reading

Acclaimed Supernatural Mystery Series The Chronicles of Chad Ryker: Supernatural Justice Receives US Review Praise and 2026 Eric Hoffer Award Nomination

San Luis Obispo, CA – R. E. Chard’s supernatural mystery series, The Chronicles of Chad Ryker: Supernatural Justice, is gaining recognition with a recommendation from The US Review of Books and a nomination for the 2026 Eric Hoffer Award. Praised for … Continue reading

Why Kowloon Machinery Is the Smartest Choice for Enterprises Seeking Tub Grinder, Metal Crusher, and Biomass Shredder Solutions in 2026

Zhengzhou Kowloon Machinery Equipment Co.,Ltd. Kowloon Machinery is a leading manufacturer and supplier of industrial recycling equipment, including tub grinders, metal crushers, biomass shredders, waste shredders, tire recycling systems, metal recycling lines, wood chippers, double shaft shredders, tire shredders, and … Continue reading

Epidermolysis Bullosa Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | RegeneRx Biopharma, BridgeBio Pharma, Berg Pharma, Holostem Terapie

Epidermolysis Bullosa pipeline constitutes 20+ key companies continuously working towards developing 21+ Epidermolysis Bullosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   “Epidermolysis Bullosa Pipeline Insight, 2026″ report by DelveInsight … Continue reading

EGFR Non Small Cell Lung Cancer Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Bridge Biotherapeutics, Sichuan Kelun Pharms, BeBetter Med, Avistone Biotech

“EGFR Non Small Cell Lung Cancer Pipeline Insight, 2026″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the EGFR Non Small Cell Lung Cancer Market.   The EGFR Non Small Cell Lung … Continue reading